The transcription factor KLF4 suppresses HCC progression by upregulating sEVs surface markers CD9 and CD81, whereas low expression of RNA helicase DDX3 promotes sEVs secretion and enhances stemness features and drug resistance in HCC cells (65, 66). Here, CD81 is linked to hepatocellular carcinoma.